BioCentury
ARTICLE | Targets & Mechanisms

AD vaccine redux

May 9, 2013 7:00 AM UTC

Researchers at Harvard Medical School have teamed up with vaccine maker Mercia Pharma Inc. to design a next-generation Alzheimer's disease vaccine with an adjuvant that promotes a beneficial anti-inflammatory

response that the team hopes will enhance b-amyloid clearance without triggering neuroinflammation.1...